- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02423746
Assessing and Addressing Behaviors in Children With Hearing Loss
Purpose:
This study is a feasibility trial of an existing evidence-based behavioral parent training program with parents of preschool-aged children who were born deaf or hard of hearing (DHH).
The hypotheses of this study are (a) that a randomized control trial of the Family Check Up with this population will be feasible, (b) parents will rate the intervention as acceptable, and (c) a signal of effect will be observable among intervention group parents compared to controls for the following outcome variables: child behaviors, parenting behaviors, and parenting sense of competence.
Study Overview
Status
Intervention / Treatment
Detailed Description
24 participants, comprising 6 parents and their preschool-aged child with a cochlear implant (CI; n=12) and 6 parents and their preschool-aged child with a hearing aid (HA; n=12) will be identified and recruited at routine clinic visits through university-affiliated hearing clinics. A dyad will consist of the child and his or her primary caregiver. Eligible participants will include children with clinically elevated behavior problems, as determined by having scored between the 70th and 90th percentiles on the Child Behavioral Checklist/1.5-5 (CBCL/1.5-5).
3 HA and 3 CI dyads will be randomized to the intervention group, and 3 HA and 3 CI dyads will be randomized to the control group. The intervention will consist of 3 Family Check-Up sessions within one month of baseline assessment. The control condition will consist of 3 behavioral placebo session within the same time frame, in which general information about healthy lifestyles will be presented. All intervention and control sessions will be delivered in the patients' usual hearing clinics. Each session will last between 60 and 90 minutes. One month post-intervention, all parent participants will complete post-test measures repeating baseline measures, plus acceptability ratings of the intervention.
Feasibility data will be collected via process measures of recruitment, retention, and session attendance. Acceptability will be measured with a parent-completed satisfaction survey. Measures of parenting behaviors, parent self-efficacy, parent-satisfaction, parent competence, child disruptive behaviors, parenting stress, and parental depression will also be piloted in preparation for a future study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- University of Kentucky
-
Lexington, Kentucky, United States, 40502
- Lexington Hearing and Speech Academy
-
Louisville, Kentucky, United States, 40203
- Heuser Hearing Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parent is age 18 years or older and the custodial guardian
- The child is aged 3-5 years and lives full-time in the caregiver's home
- The child has had a hearing aid or cochlear implant for at least 6 months and is currently being treated for hearing loss
- The child scores above the 70th but below the 90th percentile on the externalizing subscale of the CBCL/1.5-575 (i.e., elevated level of disruptive behavior problems without clear need for specialized behavioral services)
- Parent can speak, understand, and read English
Exclusion Criteria:
- The child has been diagnosed with a severe developmental condition (e.g., extreme developmental delay, severe autism, or debilitating neurological conditions, for which this intervention may not be adequate or appropriate)
- The parent already has accessed behavioral health services for the child
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control Group
The control group will include 3 hearing aid (HA) and 3 cochlear implant (CI) caregiver-child dyads. Parents in the control group will receive an initial assessment session followed by three behavioral placebo sessions followed by a post-placebo-intervention assessment. All sessions will be delivered in the patients' usual hearing clinics and will last between 60 and 90 minutes. One month post-intervention, participants will complete post-test measures repeating baseline measures, plus acceptability ratings of intervention. |
The Behavioral Placebo sessions will consist of presentations of information about healthy lifestyles. Parents in the control group will receive an initial assessment session followed by three behavioral placebo sessions followed by a post-placebo-intervention assessment. All sessions will be delivered in the patients' usual hearing clinics and will last between 60 and 90 minutes. One month post-intervention, participants will complete post-test measures repeating baseline measures, plus acceptability ratings of intervention. |
Experimental: Intervention Group
The intervention group will include 3 hearing aid (HA) and 3 cochlear implant (CI) caregiver-child dyads. Intervention parents receive the initial assessment session followed by the 3-session Family Check Up Behavioral Parenting Training Program (BPT) within one month of baseline assessment followed by a post-intervention assessment. All sessions will be delivered in the patients' usual hearing clinics and will last between 60 and 90 minutes. One month post-intervention, participants will complete post-test measures repeating baseline measures, plus acceptability ratings of intervention. |
The Family Check Up is an evidence-based Behavioral Parenting Training (BPT) program focused on harnessing parents' motivation to change and skills training. Intervention parents receive the initial assessment session followed by 3 Family Check-up Sessions within one month of baseline assessment followed by a post-intervention assessment. All sessions will be delivered in the patients' usual hearing clinics and will last between 60 and 90 minutes. One month post-intervention, participants will complete post-test measures repeating baseline measures, plus acceptability ratings of intervention. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of sessions attended by each enrolled parent
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ability to recruit 12 parent-child dyas in the allotted time frame
Time Frame: 10 months
|
10 months
|
|
COACH fidelity rating form
Time Frame: 10 months months
|
Measuring interventionist adherence and competence
|
10 months months
|
Time required per participant to complete all instruments
Time Frame: Up to 3 hours
|
Up to 3 hours
|
|
Proportion of missing data across all instruments and within each instrument
Time Frame: 4 months
|
4 months
|
|
Proportions of each full instrument and interview that are successfully completed
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christina R Studts, PhD, University of Kentucky
- Principal Investigator: Matthew L Bush, MD, University of Kentucky
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1012142740-CTSAPilot-Bush
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit and Disruptive Behavior Disorders
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit and Disruptive Behavior DisorderUnited States
-
Baylor College of MedicineCompletedAttention Deficit and Disruptive Behavior Disorders | Attention Deficit Hyperactivity DisorderUnited States
-
Erzurum Regional Training & Research HospitalCompletedAttention Deficit and Disruptive Behavior DisordersTurkey
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
New York UniversityCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder | Disruptive BehaviorUnited States
-
Oregon Research InstituteNational Institute on Drug Abuse (NIDA)CompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Child Disruptive Behavior DisordersUnited States
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Hyperactivity Disorder | Mood Disorder | Attention Deficit and Disruptive Behavior Disorder | Mental Disorder Diagnosed in ChildhoodUnited States
-
University of South CarolinaUniversity of Georgia; Oregon Research Institute; The University of QueenslandCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Childhood Disruptive Behavior Disorders | Parent-Child InteractionsUnited States
-
Chiba UniversityCompletedAttention Deficit and Disruptive Behavior Disorders | Hyperkinesis | Attention Deficit Disorder With Hyperactivity DiseaseJapan
-
Tufts Medical CenterNational Institute of Mental Health (NIMH)CompletedAttention Deficit and Disruptive Behavior Disorders | Attention Deficit Disorder With HyperactivityUnited States
Clinical Trials on Behavioral Placebo
-
Osmaniye Korkut Ata UniversityRecruitingEarthquake VictimTurkey
-
Achieve Life SciencesCompletedSmoking CessationUnited States
-
Achieve Life SciencesCompletedSmoking CessationUnited States
-
University of KentuckyNational Institute of Nursing Research (NINR)Completed
-
Merck Sharp & Dohme LLCTerminated
-
Wenzhou Medical UniversityWuhan University; Second Affiliated Hospital, School of Medicine, Zhejiang... and other collaboratorsCompletedDepression | Breast Cancer | AnxietyChina
-
CHU de Quebec-Universite LavalCanadian Breast Cancer Research AllianceCompleted
-
University of RochesterNational Cancer Institute (NCI)RecruitingCancer | Myeloid NeoplasmUnited States
-
Indiana UniversityIndiana Clinical and Translational Sciences InstituteCompletedCOVID19 Behavioral ProphylaxisUnited States